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ABSTRACT Ferrocytochrome b562 [Fe(II)cyt b562] folding
can be triggered by photoinduced electron transfer to un-
folded Fe(III)cyt b562 in 2–3 M guanidine hydrochloride
solutions. The folding rates increase with decreasing guani-
dine hydrochloride; the extrapolated time constant for this
folding process in the absence of denaturant (5 ms) is near the
predicted value for intrachain diffusion. The relatively smooth
energy landscape indicated for Fe(II)cyt b562 folding accords
with the helical, highly symmetrical structure of the protein.
Spontaneous refolding of proteins occurs on timescales that
range from microseconds to hours (1–10). Cytochrome b562
(cyt b562), a soluble 106-residue heme protein from Escherichia
coli (11–14), folds relatively rapidly (9, 15). The protein is
comprised of four antiparallel a-helices that wrap into a
left-handed bundle; the heme is inserted among the helices,
axially ligated by Met7 and His102 (Fig. 1) (16). The heme
reduction potential in the folded state [189 mV vs. normal
hydrogen electrode (pH 7) (17)] is '330 mV higher than in the
unfolded form [2150 mV (18, 19)], indicating that the driving
force for folding is greater for the reduced than for the
oxidized protein (9, 15, 20, 21). Guanidine hydrochloride
(GuHCl) reversibly unfolds the oxidized protein with a mid-
point at 1.8 M (pH 7). Unfolding the reduced protein requires
a GuHCl concentration .5 M and, owing to heme dissociation,
is irreversible. Under suitable denaturing conditions (2 M #
[GuHCl] # 3 M), electron transfer to unfolded Fe(III)cyt b562
initiates folding of the reduced protein. Earlier, it was reported
that the native low-spin Fe(II) protein forms '1 ms after
photochemical electron transfer to unfolded Fe(III)cyt b562
(15).
We have investigated the dependence of the Fe(II)cyt b562
folding kinetics on GuHCl concentration. Extrapolation of the
observed rate constants to zero denaturant concentration
suggests that the folding of this four-helix-bundle in water
approaches the theoretical speed limit for intrachain diffusion
of the polypeptide.
MATERIALS AND METHODS
Guanidine hydrochloride (Sigma, ultrapure grade), tris(2,
29-bipyridine)ruthenium(II) chloride (Strem, Newburyport,
MA), and 1,4-dihydronicotinamide adenine dinucleotide
(NADH, Sigma) were used as received. Para-methoxydimethy-
laniline (pMDMA) was synthesized according to a published
procedure (22).
Plasmid (pNS207), containing the cytochrome b562 gene
(provided by S. G. Sligar, University of Illinois), was expressed
in E. coli (strain BL21). Cyt b562 was isolated and purified
according to a procedure given by Farrow (23). The purity of
proteins used in all experiments was assessed from the 418:280
nm absorbance (A418yA280 5 5.6–6.0). Protein concentrations
were determined by using the extinction coefficients «418 5
0.117 mM21zcm21 [Fe(III)] and «426 5 0.180 mM21zcm21
[Fe(II)] (12, 24). Unfolding curves for Fe(III)- and Fe(II)cyt
b562 were generated from absorption and far-UV circular
dichroism spectra according to standard procedures (25). In
experiments with the Fe(II) protein, a slight excess of sodium
dithionite was added to keep the unfolded protein in the
reduced state. GuHCl stock solutions were adjusted to pH
7.0–7.1 by using 1.0 M NaOH. The concentration of GuHCl
was determined through measurements of the solution refrac-
tive index (Milton Roy Abbe-3L Refractometer) (25).
Steady-stateabsorptionspectraweremeasuredonaHewlett–
Packard 8452 diode array spectrophotometer. Circular dichro-
ism spectra were obtained by using an Aviv 62ADS spectropo-
larimeter (Aviv Associates, Lakewood, NJ). Transient absorp-
tion kinetics measurements were made as described (26). The
excitation source was a XeCl excimer-pumped dye laser (480
nm, 25 ns, 1–4 mJ) in experiments with Ru(bpy)321 and the
third harmonic (355 nm) of a Q-switched Nd:YAG laser in
experiments using NADH as the photoreductant. Samples for
folding kinetics measurements were held in 1-mm sealed
cuvettes (0.8–1.5 ml) and contained the following: cyt b562
(15–100 mM); either Ru(bpy)321 (1.0–1.5 equivalent) and
pMDMA ('10 mM) or NADH (2.0–2.5 equivalent); and
GuHCl (2–3 M, pH 6.6). Samples were deoxygenated by
repeated evacuationyAr-fill cycles on a Schlenk line. At each
GuHCl concentration, the reported rate constant is an average
of several kinetics traces.
The yield of folded reduced protein (Ff), relative to un-
folded reduced protein generated by laser excitation, was
calculated from initial and final absorption changes at each
GuHCl concentration. The extinction coefficient for the un-
folded reduced protein was determined by using a reductive
f lash quench procedure. Laser-excited Ru(bpy)321 was
quenched with pMDMA to generate Ru(bpy)31 and pM-
DMAz1. The concentrations of the charge separated products
were determined from their molar difference spectra. The
photochemically generated Ru(bpy)31 reduces unfolded
Fe(III)cyt b562 in ,10 ms. On complete reduction of the heme,
the transient spectrum contains contributions from
pMDMA•1 and unfolded Fe(II)cyt b562 at known concentra-
tions. Extinction coefficients for unfolded Fe(II)cyt b562 then
were determined from the transient kinetics at various wave-
lengths by subtracting the contribution from pMDMA•1.
The observed rate constant (kobsd) was interpreted as the
sum of a folding rate constant (kf) and a dissociation rate
constant (kdiss):
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kobsd 5 kf 1 kdiss
kf 5 kobsdFf
Folding rate constants were extracted from observed rates by
using the spectroscopically determined folding yields.
RESULTS
The absorption spectra of the oxidized and reduced states of
folded cyt b562 show Soret-region features that are charac-
teristic of low-spin d5 and d6 hemes (19). On GuHCl
denaturation of Fe(III)cyt b562, the Soret absorption blue-
shifts, broadens, and loses intensity at the maximum; these
changes in the spectrum ref lect the formation of a high-spin
d5 heme (Fig. 2). GuHCl titrations probed by changes in
absorbance or circular dichroism spectra indicate that the
unfolding midpoint for Fe(III)cyt b562 (1.8 M) is much lower
than that for reduced protein (5.7 M) (Fig. 3). The unfolded
oxidized protein spontaneously refolds on dilution of Gu-
HCl, confirming that the heme stays bound to the polypep-
tide for protein concentrations .10 mM (27). Unfolded
Fe(II)cyt b562, however, does not readily refold on dilution
of the denaturant; heme dissociation is likely responsible for
this behavior. Between 2 and 3 M GuHCl (pH 7), a signif-
icant amount of folded Fe(II)cyt b562 is observed on addition
of sodium dithionite to solutions of unfolded Fe(III)cyt b562
(2.33 M GuHCl, 50% yield; 3.02 M, 30%). At higher GuHCl
concentrations, heme dissociation from the peptide appears
to be faster than protein folding. Measurements of Fe(II)cyt
b562 kinetics were, therefore, confined to the 2–3 M GuHCl
concentration range.
The folding of Fe(II)cyt b562 was initiated by laser excitation
(355 nm) of NADH to produce two powerful reductants, a
solvated electron and the NAD• radical (15, 28, 29). The initial
transient spectrum (,100 ms) reflects formation of reduced
unfolded protein. The transient spectrum recorded 10 ms after
excitation (2.5 M GuHCl) agrees well with steady-state ab-
sorption differences between unfolded Fe(III)cyt b562 and
folded Fe(II)cyt b562 (15), indicating that folding has occurred
on this timescale. Kinetics were monitored by Soret absorption
changes (400–430 nm) that indicate the formation of a low-
spin ferroheme. The folding reactions were slower at higher
GuHCl concentrations; the observed first-order rate constants
(kobsd) range from 3.3(7) 3 103 to 7.4(9) 3 103 s21 (2–3 M
GuHCl). Specific rate constants for formation of low-spin
folded cyt b562, extracted from the observed rate constants,
vary from 1.5(2) 3 103 (2.2 M GuHCl) to 3.0(9) 3 102 s21 (3.0
M GuHCl) (Fig. 4). (The rate constants for the competing
heme-dissociation process range from 3 to 7 3 103 s21 between
2 and 3 M GuHCl.) Although a relatively narrow range of
GuHCl concentrations was explored, there appears to be a
linear relationship between the logarithm of the folding rate
and the GuHCl concentration (Fig. 4). Extrapolation to 0 M
GuHCl suggests a time constant of '5 ms for folding Fe(II)cyt
b562 in water.‡
DISCUSSION
A recent molecular-dynamics simulation carried out on an
unfolded 36-residue protein suggests that partly folded struc-
‡Note that the highest measured rate is 1.5 3 103 s21 (at 2.2 M
GuHCl).
FIG. 1. Cyt b562 structure (Brookhaven Protein Data Bank, acces-
sion no. 256B). The heme is coordinated by two axial ligands, Met 7
and His 102. The cytochrome b562 bundle is in an up-down-up-down
arrangement, with the four helices almost perfectly parallel to each
other.
FIG. 2. Soret absorption of folded Fe(III) (dashed line), folded
Fe(II) (solid line), and unfolded Fe(III) (dotted line) cyt b562.
FIG. 3. Denaturant-induced unfolding of Fe(III) and Fe(II) cyto-
chrome b562, pH 7.
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tures can occur within tens of nanoseconds (30). Experimental
studies on apomyoglobin (134 residues) indicate that some
secondary structure forms in the first 10 ms of folding (31, 32).
Polymer diffusion models have been used to estimate that the
minimum time constant for folding a small, single-domain
protein to its native structure is on the order of 1 ms (8, 33).
More recent estimates suggest a lower limit of 0.2 ms for
protein folding (34). Our extrapolated folding time for Fe(I-
I)cyt b562 approaches this limit.
Another four-helix bundle, the acyl CoA binding protein
(ACBP), folds more slowly than Fe(II)cyt b562 [700 s21, 20°C
(35, 36)]. ACBP has a so-called up-down-down-up four-helix
bundle structure held together by hydrophobic junctions,
where the helices interact pairwise or in groups of three (37).
By contrast, the cyt b562 bundle is an up-down-up-down
arrangement, and the four helices are almost perfectly parallel
to each other (16). ACBP is less stable than Fe(II) cyt b562
[2DGf 5 29 (35, 36) and '43 kJymol (15), respectively], a
property that may affect the folding kinetics, because, in
general, the tertiary folds of these two proteins are similar.
Although reduced horse heart cytochrome c is much more
stable [2DGf 5 74 kJymol (38)] than Fe(II)cyt b562, it folds
much more slowly [estimated folding time of 100 ms in aqueous
solution (20, 28, 38)]. Part of the difference is undoubtedly
attributable to ligand substitution kinetics that retard the
folding of cytochrome c (28). But even at reduced pH, where
the heme in unfolded cytochrome c is not misligated, protein
folding is still slower than for cyt b562 (5).
Why does folding of Fe(II)cyt b562 occur near the maximum
speed limit when the folding of other helical proteins is much
slower? Theoretical analysis indicates that symmetrical struc-
tures will have relatively smooth energy landscapes for folding
(1, 39), and the up-down-up-down four-helix-bundle structure
of cytochrome b562 is one of the most symmetrical of protein
architectures. It is interesting to note that an inverse correla-
tion between folding rates and contact order (the average
relative sequence separation of native contacts) has been
observed for a set of single-domain proteins that exhibit
two-state folding (40). Although two-state folding has not yet
been confirmed in cyt b562, the contact order of this protein is
extremely low, 7.5% (K. W. Plaxco, personal communication),
which is consistent with its very local, all helical structure (16).
This low contact order corresponds to a predicted folding time
of '10 ms, which is in good agreement with our extrapolated
value of 5 ms. The longer folding times of the helical proteins
cytochrome c and ACBP (20, 28, 35, 36, 38) are consistent with
the predictions of the contact-order model (contact orders: cyt
c, 11.2%; ACBP, 14%) (40).
The fast folding observed for cyt b562 may be a consequence
of the competing heme-dissociation step. Unfolded cyt b562 is
expected to be an ensemble of randomly configured, heme-
bound polypeptides. The kinetics for conversion of this en-
semble into a homogeneous population of folded proteins
could be highly heterogenous. Some configurations in the
unfolded ensemble could fold quite rapidly whereas others
might require much longer times (41). This division of the
unfolded ensemble into fast and slow folding populations can
have important implications when a second process competes
with folding. In Fe(II)cyt b562, it is possible that only fast
folding is observed because the heme dissociates from the
slow-folding configurations. Because the free heme has a
relatively weak spectroscopic signature, its presence would be
difficult to detect amid a population of folded reduced protein.
If heme dissociation does select against slow folding configu-
rations in Fe(II)cyt b562, then we expect that four-helix bundle
c-type heme proteins [e.g., cytochrome c9 (11, 42)] would
require much longer times to form fully folded ensembles.
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